New York, NY (PRWEB) May 04, 2015
NewYork-Presbyterian/Weill Cornell Medical Center has appointed two chiefs to lead its liver transplant program, effective April 1. Dr. Robert S. Brown, Jr. has been named chief of liver transplantation in the Joan and Sanford I. Weill Department of Medicine, while Dr. Benjamin Samstein will serve as chief of liver transplantation and hepatobiliary surgery in the Department of Surgery. Both serve on the faculty of Weill Cornell Medical College and Columbia University College of Physicians and Surgeons.
Dr. Robert Brown
Dr. Robert Brown is the chief of liver transplantation in the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medical College and NewYork-Presbyterian/Weill Cornell. He also serves as hepatology section director in the Division of Gastroenterology and vice chair of transitions of care in the Weill Department of Medicine.
An internationally renowned expert in liver disease and liver transplantation, Dr. Brown uses innovative methods to expand access to transplants and improve quality of life for patients with liver failure. In addition to his work in transplant medicine, he has been involved with clinical trials for artificial liver support and treatments for hepatitis B and C.
He has published more than 190 peer-reviewed articles and is an associate editor for Liver Transplantation. In addition, he wrote a book, “Common Liver Diseases and Transplantation: An Algorithmic Approach to Work-up and Management.” An influential member of the transplant community, he is a member of the International Liver Transplantation Society, the American Society of Transplant Physicians and serves on the nominating committee of the American Association for the Study of Liver Diseases.
Dr. Brown is board certified in medicine, gastroenterology and transplant hepatology. He received his bachelor degree from Harvard College, his medical degree from New York University and his Master of Public Health from the Graduate School of Public Health, University of California in Berkeley. He completed an internship in medicine at Beth Israel Hospital (now Beth Israel Deaconess Medical Center) in Boston and a fellowship in gastroenterology and hepatology at the University of California, San Francisco.
Dr. Benjamin Samstein
Dr. Benjamin Samstein has been named chief of liver transplantation and hepatobiliary surgery in the Department of Surgery at Weill Cornell Medical College and NewYork-Presbyterian/Weill Cornell.
Dr. Samstein is a renowned liver transplant surgeon known for his pioneering efforts in laparoscopic liver donation. He specializes in laparoscopic procedures for liver cancer, benign liver tumors and hepatobiliary pancreas disease, and treats conditions such as hepatic adenoma, hepatic hemangioma, cholangiocarcinoma and colorectal metastasis.
Board certified in surgery, Dr. Samstein has received numerous awards and honors for his work in the field. His research has been published in prestigious publications such as the New England Journal of Medicine, The American Journal of Transplantation and Nature Medicine. He is a member of American Society of Transplant Surgeons, and serves on the United Network for Organ Sharing (UNOS ) Liver & Intestine Committee representing Region 9, which includes New York and southern Vermont.
Dr. Samstein received his undergraduate degree from Cornell University and earned his medical degree at the State University of New York at Stony Brook. He did his internship and residency in general surgery at NewYork-Presbyterian/Columbia University Medical Center, and completed a research fellowship at the Mayo Clinic in 2001. He also completed an American Society of Transplant Surgeons Multi-Organ Transplant Fellowship at NewYork-Presbyterian/Columbia in 2006.
NewYork-Presbyterian/Weill Cornell Medical Center
NewYork-Presbyterian/Weill Cornell Medical Center, located in New York City, is one of the leading academic medical centers in the world, comprising the teaching hospital NewYork-Presbyterian and Weill Cornell Medical College, the medical school of Cornell University. NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine, and is committed to excellence in patient care, education, research and community service. Weill Cornell physician-scientists have been responsible for many medical advances — including the development of the Pap test for cervical cancer; the synthesis of penicillin; the first successful embryo-biopsy pregnancy and birth in the U.S.; the first clinical trial for gene therapy for Parkinson’s disease; the first indication of bone marrow’s critical role in tumor growth; and, most recently, the world’s first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. NewYork-Presbyterian Hospital also comprises NewYork-Presbyterian/Columbia University Medical Center, NewYork-Presbyterian/Morgan Stanley Children’s Hospital, NewYork-Presbyterian/Westchester Division, NewYork-Presbyterian/The Allen Hospital, and NewYork-Presbyterian/Lower Manhattan Hospital. The hospital is also closely affiliated with NewYork-Presbyterian/Hudson Valley Hospital and NewYork-Presbyterian/Lawrence Hospital. NewYork-Presbyterian is the #1 hospital in the New York metropolitan area, according to U.S. News & World Report, and consistently named to the magazine’s Honor Roll of best hospitals in the nation. Weill Cornell Medical College is the first U.S. medical college to offer a medical degree overseas and maintains a strong global presence in Austria, Brazil, Haiti, Tanzania, Turkey and Qatar. For more information, visit http://www.nyp.org and weill.cornell.edu.